Published in J Clin Invest on September 15, 1996
Enhanced protein domain discovery using taxonomy. BMC Bioinformatics (2004) 1.81
Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803. Biochem J (2002) 1.61
Impaired placentation in fetal alcohol syndrome. Placenta (2007) 1.21
Differential growth factor regulation of aspartyl-(asparaginyl)-beta-hydroxylase family genes in SH-Sy5y human neuroblastoma cells. BMC Cell Biol (2006) 1.04
Ethanol inhibition of aspartyl-asparaginyl-beta-hydroxylase in fetal alcohol spectrum disorder: potential link to the impairments in central nervous system neuronal migration. Alcohol (2009) 1.04
Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver. Hepatology (2009) 1.01
Aspartyl-(asparaginyl) beta-hydroxylase, hypoxia-inducible factor-alpha and Notch cross-talk in regulating neuronal motility. Oxid Med Cell Longev (2010) 0.94
A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma. Hepatology (2014) 0.94
siRNA inhibition of aspartyl-asparaginyl β-hydroxylase expression impairs cell motility, Notch signaling, and fetal growth. Pathol Res Pract (2011) 0.92
Upregulation of T-cell factor-4 isoform-responsive target genes in hepatocellular carcinoma. Liver Int (2013) 0.91
Prognostic value of aspartyl (asparaginyl)-beta-hydroxylase/humbug expression in non-small cell lung carcinoma. Hum Pathol (2009) 0.90
Role of aspartyl-(asparaginyl)-β-hydroxylase mediated notch signaling in cerebellar development and function. Behav Brain Funct (2010) 0.86
Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma. J Hepatol (2012) 0.85
Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival. Br J Cancer (2009) 0.84
Gene-environment interactions of novel variants associated with head and neck cancer. Head Neck (2011) 0.82
Glial vascular degeneration in CADASIL. J Alzheimers Dis (2010) 0.81
HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma. Onco Targets Ther (2014) 0.80
Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotype. Oncotarget (2015) 0.80
Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma. Hepatology (2016) 0.80
Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression. PLoS One (2016) 0.79
Ceramide inhibitor myriocin restores insulin/insulin growth factor signaling for liver remodeling in experimental alcohol-related steatohepatitis. J Gastroenterol Hepatol (2013) 0.79
Potential Role of Phosphorylation as a Regulator of Aspartyl-(asparaginyl)-β-hydroxylase: Relevance to Infiltrative Spread of Human Hepatocellular Carcinoma. Liver Cancer (2015) 0.78
Immunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma. Hepatology (2012) 0.77
Precision-cut slice culture method for rat placenta. Placenta (2011) 0.76
Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma. Vaccine (2015) 0.76
Aspartate-β-hydroxylase (ASPH): A potential therapeutic target in human malignant gliomas. Heliyon (2016) 0.75
The Eighth Central European Conference "Chemistry towards Biology": Snapshot. Molecules (2016) 0.75
Optimized Expression and Purification of Humbug in Pichia pastoris and Its Monoclonal Antibody Preparation. Iran J Public Health (2015) 0.75
A Radiolabeled Fully Human Antibody to Human Aspartyl (Asparaginyl) β-Hydroxylase Is a Promising Agent for Imaging and Therapy of Metastatic Breast Cancer. Cancer Biother Radiopharm (2017) 0.75
Regulation of Aspartyl-(Asparaginyl)-β-Hydroxylase Protein Expression and Function by Phosphorylation in Hepatocellular Carcinoma Cells. J Nat Sci (2015) 0.75
Motor Function Deficits Following Chronic Prenatal Ethanol Exposure are Linked to Impairments in Insulin/IGF, Notch and Wnt Signaling in the Cerebellum. J Diabetes Metab (2013) 0.75
Development of a novel anti-human aspartyl-(asparaginyl) β-hydroxylase monoclonal antibody with diagnostic and therapeutic potential. Oncol Lett (2017) 0.75
Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma. Heliyon (2017) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res (1984) 181.98
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun (1978) 32.33
TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell (1991) 10.06
Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc Natl Acad Sci U S A (1988) 7.48
Predicting the orientation of eukaryotic membrane-spanning proteins. Proc Natl Acad Sci U S A (1989) 5.15
Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med (1996) 4.79
The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell (1995) 4.13
Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. Proc Natl Acad Sci U S A (1996) 4.13
The intracellular domain of mouse Notch: a constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD. Development (1994) 3.99
Antineurogenic phenotypes induced by truncated Notch proteins indicate a role in signal transduction and may point to a novel function for Notch in nuclei. Genes Dev (1993) 3.86
Intrinsic activity of the Lin-12 and Notch intracellular domains in vivo. Cell (1993) 3.53
Specific truncations of Drosophila Notch define dominant activated and dominant negative forms of the receptor. Cell (1993) 3.35
The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol (1993) 2.95
An N-terminal double-arginine motif maintains type II membrane proteins in the endoplasmic reticulum. EMBO J (1994) 2.65
Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev (1992) 2.59
An activated Notch receptor blocks cell-fate commitment in the developing Drosophila eye. Nature (1993) 2.49
An activated Notch suppresses neurogenesis and myogenesis but not gliogenesis in mammalian cells. Development (1994) 2.46
Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature (1995) 2.45
Expression of an extracellular deletion of Xotch diverts cell fate in Xenopus embryos. Cell (1993) 2.19
Cytosolic interaction between deltex and Notch ankyrin repeats implicates deltex in the Notch signaling pathway. Development (1994) 1.73
Establishment and characterization of a new human hepatocellular carcinoma cell line. In Vitro (1984) 1.43
Unique chromosomal rearrangement and mucin production in a novel salivary myoepithelial cell strain. Arch Otolaryngol Head Neck Surg (1993) 1.41
Structure-function relationships of epidermal growth factor modules in vitamin K-dependent clotting factors. Blood (1991) 1.38
Control of cell fate in C. elegans by a GLP-1 peptide consisting primarily of ankyrin repeats. Nature (1993) 1.35
beta-Hydroxyasparagine in domains homologous to the epidermal growth factor precursor in vitamin K-dependent protein S. Proc Natl Acad Sci U S A (1987) 1.20
cDNA cloning and expression of bovine aspartyl (asparaginyl) beta-hydroxylase. J Biol Chem (1992) 1.19
A novel endocytosis signal related to the KKXX ER-retrieval signal. EMBO J (1995) 1.13
Bovine liver aspartyl beta-hydroxylase. Purification and characterization. J Biol Chem (1991) 1.03
Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma. Mol Cell Biol (1990) 1.03
Further evidence for function of the Drosophila Notch protein as a transmembrane receptor. Proc Natl Acad Sci U S A (1993) 1.02
Partial purification and characterization of bovine liver aspartyl beta-hydroxylase. J Biol Chem (1990) 1.00
A fully active catalytic domain of bovine aspartyl (asparaginyl) beta-hydroxylase expressed in Escherichia coli: characterization and evidence for the identification of an active-site region in vertebrate alpha-ketoglutarate-dependent dioxygenases. Proc Natl Acad Sci U S A (1994) 0.93
Invertebrate aspartyl/asparaginyl beta-hydroxylase: potential modification of endogenous epidermal growth factor-like modules. Biochem Biophys Res Commun (1992) 0.93
Cloning and characterization of the human gene encoding aspartyl beta-hydroxylase. Gene (1994) 0.93
Aspartyl beta-hydroxylase: in vitro hydroxylation of a synthetic peptide based on the structure of the first growth factor-like domain of human factor IX. Proc Natl Acad Sci U S A (1989) 0.91
Human hepatoma-associated cell surface antigen: identification and characterization by means of monoclonal antibodies. Hepatology (1985) 0.90
In vivo expression of two novel tumor-associated antigens and their use in immunolocalization of human hepatocellular carcinoma. Hepatology (1989) 0.85
Cell-surface changes associated with transformation of human hepatocytes to the malignant phenotype. Proc Natl Acad Sci U S A (1988) 0.84
Relationship of cytogenetic subtypes of salivary gland pleomorphic adenomas with patient age and histologic type. Cancer (1989) 0.82
FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo) (1987) 7.07
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature (1999) 5.53
FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) (1987) 4.54
A ligand-gated association between cytoplasmic domains of UNC5 and DCC family receptors converts netrin-induced growth cone attraction to repulsion. Cell (1999) 4.25
Transcriptional repression: the long and the short of it. Genes Dev (2001) 2.91
A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med (1991) 2.68
Topological phase transition and texture inversion in a tunable topological insulator. Science (2011) 2.68
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 2.59
Hepatitis C virus: epidemiology and transmission. Hepatology (1997) 2.43
Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitors. J Biol Chem (2000) 2.33
Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Proc (1987) 2.30
Circulating immune complexes and complement activation in primary biliary cirrhosis. N Engl J Med (1978) 2.30
Antibiotics and nucleic acids. Annu Rev Biochem (1971) 2.20
Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology (1996) 2.18
The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes. J Clin Invest (1975) 2.13
Nucleotide sequence of the streptothricin acetyltransferase gene from Streptomyces lavendulae and its expression in heterologous hosts. J Bacteriol (1987) 2.08
Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology (1975) 2.08
Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology (1998) 2.01
Posttranscriptional regulation of hepatitis B virus replication by the precore protein. J Virol (1997) 1.96
Calcium signalling in the guidance of nerve growth by netrin-1. Nature (2000) 1.96
Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J Virol (1998) 1.96
The increasing incidence of hepatocellular carcinoma. N Engl J Med (1999) 1.92
Hepatitis B virus X protein is not central to the viral life cycle in vitro. J Virol (1992) 1.92
Oxygen-dependent cleavage of DNA by the 1,10-phenanthroline . cuprous complex. Inhibition of Escherichia coli DNA polymerase I. J Biol Chem (1979) 1.91
The native form and maturation process of hepatitis C virus core protein. J Virol (1998) 1.91
Primary hepatocellular carcinoma. N Engl J Med (1991) 1.91
Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med (1990) 1.85
Sodic soils reclaimed with by-product from flue gas desulfurization: corn production and soil quality. Environ Pollut (2001) 1.76
Decreased suppressor cell activity in inflammatory bowel disease. Clin Exp Immunol (1978) 1.75
Laparoscopic omental patch repair for perforated peptic ulcer. Ann Surg (1995) 1.74
Polyisoprenylation of Ras in vitro by a farnesyl-protein transferase. J Biol Chem (1990) 1.68
Normal serum ferritin concentrations in precirrhotic hemochromatosis. N Engl J Med (1976) 1.68
A prokaryotic gene cluster involved in synthesis of lysine through the amino adipate pathway: a key to the evolution of amino acid biosynthesis. Genome Res (1999) 1.65
Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc Natl Acad Sci U S A (1987) 1.63
Cell-mediated immunity in acute and chronic hepatitis. J Clin Invest (1975) 1.63
Phenylketonuria in adulthood: a collaborative study. J Inherit Metab Dis (2002) 1.61
Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol (1991) 1.61
Development of a host-vector system in a Rhodococcus strain and its use for expression of the cloned nitrile hydratase gene cluster. J Gen Microbiol (1992) 1.60
Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer (2008) 1.59
Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization. Gastroenterology (1997) 1.58
Primary structure of AfsR, a global regulatory protein for secondary metabolite formation in Streptomyces coelicolor A3(2). Gene (1990) 1.57
Alteration in suppressor cell activity in chronic active hepatitis. Proc Natl Acad Sci U S A (1978) 1.57
Hepatitis B transmission by dentists. JAMA (1974) 1.57
High affinity monoclonal antibodies to hepatitis B surface antigen (HBsAg) produced by somatic cell hybrids. Gastroenterology (1981) 1.55
Partial purification and characterization of tryptophan hydroxylase from rabbit hindbrain. J Biol Chem (1972) 1.53
Pressor effect of naloxone in septic shock. Lancet (1981) 1.53
Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame. Virology (1997) 1.52
Cloning and sequencing of the gene cluster encoding two subunits of membrane-bound alcohol dehydrogenase from Acetobacter polyoxogenes. Biochim Biophys Acta (1991) 1.51
Nucleotide sequence and transcriptional analysis of the Streptomyces griseus gene (afsA) responsible for A-factor biosynthesis. J Bacteriol (1989) 1.50
Amidase coupled with low-molecular-mass nitrile hydratase from Rhodococcus rhodochrous J1. Sequencing and expression of the gene and purification and characterization of the gene product. Eur J Biochem (1993) 1.50
Immunodiagnosis of hepatitis B with high-affinity IgM monoclonal antibodies. Proc Natl Acad Sci U S A (1981) 1.48
Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection. J Virol (1995) 1.48
Echistatin. A potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus. J Biol Chem (1988) 1.45
Establishment and characterization of a new human hepatocellular carcinoma cell line. In Vitro (1984) 1.43
Tight clustering of human hepatitis B virus integration sites in hepatomas near a triple-stranded region. J Virol (1987) 1.42
Nucleotide sequence of the malate dehydrogenase gene of Thermus flavus and its mutation directing an increase in enzyme activity. J Biol Chem (1986) 1.42
Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest (1999) 1.42
A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals. Proc Natl Acad Sci U S A (1998) 1.42
Fulminant hepatitis complicated by pancreatitis. Johns Hopkins Med J (1973) 1.40
Arthritis associated with intestinal-bypass procedure for morbid obesity. Complement activation and characterization of circulating cryoproteins. N Engl J Med (1976) 1.39
Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med (2001) 1.38
Rapid identification of low level hepatitis B-related viral genome in serum. J Clin Invest (1989) 1.37
Toxicologic evaluation of FK 506. Transplant Proc (1990) 1.36
Interaction of anthelmintic benzimidazoles and benzimidazole derivatives with bovine brain tubulin. Biochim Biophys Acta (1978) 1.36
Intra-atrial conduction block along the mitral valve annulus during accessory pathway ablation: evidence for a left atrial "isthmus". J Cardiovasc Electrophysiol (2001) 1.36
Stethoscope acoustics. II. Transmission and filtration patterns. Circulation (1966) 1.35
Aspartyl beta -hydroxylase (Asph) and an evolutionarily conserved isoform of Asph missing the catalytic domain share exons with junctin. J Biol Chem (2000) 1.33
Mechanism of calcium transport stimulated by chlorothiazide in mouse distal convoluted tubule cells. J Clin Invest (1992) 1.31
Diffuse Lewy body disease and progressive dementia. Neurology (1988) 1.31
Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J Neurol Sci (1997) 1.31
Quantitative lymph imaging for assessment of lymph function using indocyanine green fluorescence lymphography. Eur J Vasc Endovasc Surg (2008) 1.31
Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J Immunol (1997) 1.30
Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides. In vitro model for selection of target sequence. J Biol Chem (1994) 1.29
Experimental study of pylorus and pyloric vagus preserving gastrectomy. World J Surg (1993) 1.29
A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen. J Biol Chem (1989) 1.27
Coexpression of Grb7 with epidermal growth factor receptor or Her2/erbB2 in human advanced esophageal carcinoma. Cancer Res (1997) 1.27
Primary structure of nitrile hydratase deduced from the nucleotide sequence of a Rhodococcus species and its expression in Escherichia coli. Eur J Biochem (1989) 1.26
Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation. Cancer Res (2000) 1.26
Indocyanine green fluorescence angiography for intraoperative assessment of blood flow: a feasibility study. Eur J Vasc Endovasc Surg (2007) 1.25
Histone deacetylase as a new target for cancer chemotherapy. Cancer Chemother Pharmacol (2001) 1.24
Determinants of protein thermostability observed in the 1.9-A crystal structure of malate dehydrogenase from the thermophilic bacterium Thermus flavus. Biochemistry (1993) 1.24
Isolation, characterization, and distribution of an unusual pancreatic human secretory protein. J Clin Invest (1985) 1.24
Inhibition of hepatic regeneration in rats by acute and chronic ethanol intoxication. Gastroenterology (1979) 1.24
Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology (1991) 1.23
Hepatitis B in an oncology unit. N Engl J Med (1974) 1.23
Monoclonal radioimmunoassays for hepatitis B surface antigen: demonstration of hepatitis B virus DNA or related sequences in serum and viral epitopes in immune complexes. Proc Natl Acad Sci U S A (1982) 1.23
Demonstration of previously undetected hepatitis B viral determinants in an Australian Aboriginal population by monoclonal anti-hbs antibody radioimmunoassays. Lancet (1982) 1.23
Transglutaminase inhibition by 2-[(2-oxopropyl)thio]imidazolium derivatives: mechanism of factor XIIIa inactivation. Biochemistry (1994) 1.22
The major histocompatibility complex class I antigen-binding protein p88 is the product of the calnexin gene. Proc Natl Acad Sci U S A (1992) 1.22
Monoclonal IgM radioimmunoassay for hepatitis B surface antigen: high binding activity in serum that is unreactive with conventional antibodies. Proc Natl Acad Sci U S A (1982) 1.22
CO2-stimulated NaCl absorption in the mouse renal cortical thick ascending limb of Henle. Evidence for synchronous Na +/H+ and Cl-/HCO3- exchange in apical plasma membranes. J Gen Physiol (1982) 1.21
Impaired placentation in fetal alcohol syndrome. Placenta (2007) 1.21
Effect of insulin and glucagon on fulminant murine hepatitis. N Engl J Med (1976) 1.20
cDNA cloning and expression of bovine aspartyl (asparaginyl) beta-hydroxylase. J Biol Chem (1992) 1.19
Chronic gestational exposure to ethanol causes insulin and IGF resistance and impairs acetylcholine homeostasis in the brain. Cell Mol Life Sci (2006) 1.19
Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease. Lab Invest (2000) 1.19
A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype. J Clin Invest (1996) 1.18
Involvement of the COOH-terminal pro-sequence of Serratia marcescens serine protease in the folding of the mature enzyme. J Biol Chem (1994) 1.18
Recent advances in the natural history of hepatocellular carcinoma. Carcinogenesis (2008) 1.18